With Love, Grandma ("Con Cariño, Abuelita") Pilot Study

Sponsor
University of Miami Sylvester Comprehensive Cancer Center (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05721976
Collaborator
The V Foundation for Cancer Research (Other)
80
1
2
12
6.7

Study Details

Study Description

Brief Summary

The purpose of this study is to assess the feasibility, acceptability, and preliminary effects of a digital (web and mobile-phone-based) program to improve lifestyle behaviors (physical activity, dietary intake) among Hispanic female cancer survivors and adult daughters.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: With Love, Grandma ("Con Cariño, Abuelita")
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Pilot Study of a Multigenerational Digital Lifestyle Intervention for Hispanic Female Cancer Survivors and Their Families
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
Apr 30, 2024
Anticipated Study Completion Date :
Apr 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: With Love, Grandma ("Con Cariño, Abuelita") Group

Cancer survivor-Daughter dyads randomized to the With Love, Grandma ("Con Cariño, Abuelita") group will access a digital lifestyle program that includes 8 modules of didactic, behavioral, and family communication/parenting/grandparenting content from smartphones over the course of 10-12 weeks.

Behavioral: With Love, Grandma ("Con Cariño, Abuelita")
Cancer survivor-Daughter dyads will log in to a secured website to access intervention content over a period of 10-12 weeks. The intervention will be delivered primarily through smartphones and will include 8 modules with didactic content on healthy lifestyle behaviors for cancer prevention and control, family behavior change content for setting weekly goals and self-monitoring health behaviors, and family communication and positive parenting/grandparenting content, all of which were developed in accordance with participant feedback based on formative intervention development work. In addition, and to increase participant compliance/reduce attrition often observed in digital health interventions, human support ("supportive accountability") will be provided. Specifically, each family will be assigned a "coach" who will use video conferencing software to engage in weekly 15-30 minute sessions regarding the family's progress throughout the intervention period.

No Intervention: Control Group

This group is intended to reflect typical services cancer survivors and family members receive from healthcare providers.

Outcome Measures

Primary Outcome Measures

  1. Percent of survivor-daughter dyads retained at post-intervention (feasibility) [Up to 3 months]

    Calculated by percent of enrolled survivor-daughter dyads who completed post-intervention measures

  2. Percent of modules completed by survivor-daughter dyads (acceptability) [Up to 3 months]

    Calculated as number of modules completed (of 8 total modules) by survivors and daughters

Secondary Outcome Measures

  1. Change in survivor and daughter physical activity as reported in the International Physical Activity Questionnaire (IPAQ) [Baseline, Up to 3 months]

    Participants will self-report walking and sitting time (hours and minutes per day) using three items from the IPAQ. Mean difference in total time spent walking and sitting will be calculated from these items. The result is not reported in scales. Higher scores indicate higher time spent walking and sitting in the last 7 days.

  2. Change in survivor and daughter physical activity as measured by the Godin Leisure Time Exercise Questionnaire [Baseline, Up to 3 months]

    Responses range from 0 - greater than 24, with 0 indicating no activity and a higher score indicating more activities (no maximum score).

  3. Change in survivor and daughter fruit and vegetable intake as measured by the NCI All-Day Screener [Baseline, Up to 3 months]

    Participants will self-report dietary intake using the NCI All-Day Screener for fruit and vegetables and the percentage of energy from fat and fiber. Mean difference in cup equivalents of fruits and vegetables will be calculated using a scoring algorithm developed by the National Cancer Institute

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Cancer Survivor Inclusion Criteria:
  • Grandmother

  • Self-identifies as Hispanic

  • Diagnosis of breast cancer (stages I-III), endometrial or ovarian cancer (stages I-II)

  • Completed active treatment (i.e., surgery, chemotherapy, and/or radiation)

  • Body Mass Index (BMI) ≥ 25 (overweight range)

  • Engages in <150 minutes/week of moderate physical activity

  • English or Spanish speaking

  • Owns a mobile device with internet access (e.g., smartphone, tablet)

  • Lives in South Florida

Daughter of Cancer Survivor Inclusion Criteria:
  • Adult daughter of the identified cancer survivor (21 years of age or older)

  • Has at least 1 living child ages ≤16 years old

  • Body Mass Index (BMI) ≥ 25 (overweight range) OR engages in <150 minutes/week of moderate physical activity

  • English or Spanish speaking

  • Owns a mobile device with internet access (e.g., smartphone, tablet)

  • Lives in South Florida

Daughter of Cancer Survivor Exclusion Criteria:
  • Has been diagnosed with distant metastatic cancer

  • Has not completed active treatment (i.e., surgery, chemotherapy, and/or radiation)

  • Has uncontrolled schizophrenia or bipolar disorder

  • Has a preexisting medical condition that precludes unsupervised physical activity (e.g., severe orthopedic conditions,wheelchair bound).

Cancer Survivor Exclusion Criteria:
  • Has uncontrolled schizophrenia or bipolar disorder

  • Has a preexisting medical condition that precludes unsupervised physical activity (e.g., severe orthopedic conditions, wheelchair bound)

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Miami Miami Florida United States 33136

Sponsors and Collaborators

  • University of Miami Sylvester Comprehensive Cancer Center
  • The V Foundation for Cancer Research

Investigators

  • Principal Investigator: Sara M St. George, PhD, University of Miami

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sara StGeorge, Assistant Professor of Public Health Sciences, University of Miami Sylvester Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT05721976
Other Study ID Numbers:
  • 20201421
  • 2018-024
First Posted:
Feb 10, 2023
Last Update Posted:
Feb 10, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sara StGeorge, Assistant Professor of Public Health Sciences, University of Miami Sylvester Comprehensive Cancer Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 10, 2023